Tabone M - Search Results

1

PET-CT post therapy dosimetry in radioembolization with resin ⁹⁰Y microspheres: Comparison with pre-treatment SPECT-CT ^99mTc-MAA results.

Richetta E, Pasquino M, Poli M, Cutaia C, Valero C, Tabone M, Paradisi BP, Pacilio M, Pellerito RE, Stasi M. Richetta E, et al. Among authors: tabone m. Phys Med. 2019 Aug;64:16-23. doi: 10.1016/j.ejmp.2019.05.025. Epub 2019 Jun 19. Phys Med. 2019. PMID: 31515015

2

Radioembolization in a Single Session Using 90-Yttrium Resin Microspheres.

Calvo A, Tabone M, Carbonatto P, Richetta E, Pellerito R. Calvo A, et al. Among authors: tabone m. J Vasc Interv Radiol. 2019 Oct;30(10):1648-1649. doi: 10.1016/j.jvir.2019.06.023. Epub 2019 Sep 9. J Vasc Interv Radiol. 2019. PMID: 31514998 No abstract available.

3

Downstaging unresectable hepatocellular carcinoma by radioembolization using 90-yttrium resin microspheres: a single center experience.

Tabone M, Calvo A, Russolillo N, Langella S, Carbonatto P, Lo Tesoriere R, Richetta E, Pellerito R, Ferrero A. Tabone M, et al. J Gastrointest Oncol. 2020 Feb;11(1):84-90. doi: 10.21037/jgo.2019.06.01. J Gastrointest Oncol. 2020. PMID: 32175109 Free PMC article.

4

Internal radiation by 131-iodine lipiodol in unresectable hepatocellular carcinoma.

Tabone M, Carbonatto P, Calvo A, Pellerito R, Stasi M, Daperno M, Rocca R. Tabone M, et al. Dig Liver Dis. 2013 Nov;45(11):962-3. doi: 10.1016/j.dld.2013.03.006. Epub 2013 Apr 12. Dig Liver Dis. 2013. PMID: 23587497 No abstract available.

5

Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.

Tabone M, Vigano' L, Ferrero A, Pellerito R, Carbonatto P, Capussotti L. Tabone M, et al. Eur J Surg Oncol. 2007 Feb;33(1):61-6. doi: 10.1016/j.ejso.2006.10.039. Epub 2006 Dec 18. Eur J Surg Oncol. 2007. PMID: 17175128

6

Adjuvant iodine-131-labeled lipiodol for prevention of intrahepatic recurrence of hepatocellular carcinoma: which is the best treatment schedule?

Tabone M, Vigano L, Laudi C, Ferrero A, Pellerito R, Capussotti L. Tabone M, et al. Hepatology. 2005 Jun;41(6):1433; author reply 1433-4. doi: 10.1002/hep.20692. Hepatology. 2005. PMID: 15834934 No abstract available.

7

Radioembolization vs sorafenib in locally advanced hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score and Bayesian analysis.

Martelletti C, Ricotti A, Gesualdo M, Carucci P, Gaia S, Rolle E, Burlone ME, Okolicsanyi S, Mattalia A, Pirisi M, Berchialla P, Tabone M. Martelletti C, et al. Among authors: tabone m. J Dig Dis. 2021 Aug;22(8):496-502. doi: 10.1111/1751-2980.13030. Epub 2021 Jul 13. J Dig Dis. 2021. PMID: 34189839 Free article.

8

Liver resection for HCC with cirrhosis: surgical perspectives out of EASL/AASLD guidelines.

Capussotti L, Ferrero A, Viganò L, Polastri R, Tabone M. Capussotti L, et al. Among authors: tabone m. Eur J Surg Oncol. 2009 Jan;35(1):11-5. doi: 10.1016/j.ejso.2007.06.005. Epub 2007 Aug 3. Eur J Surg Oncol. 2009. PMID: 17689043

9

A strong negative association between alcohol consumption and the risk of hepatocellular carcinoma in cirrhotic patients. A case-control study.

Aricó S, Corrao G, Torchio P, Galatola G, Tabone M, Valenti M, Di Orio F. Aricó S, et al. Among authors: tabone m. Eur J Epidemiol. 1994 Jun;10(3):251-7. doi: 10.1007/BF01719346. Eur J Epidemiol. 1994. PMID: 7859834

10

Prevention of intrahepatic hepatocarcinoma recurrence in patients with viral cirrhosis: two potential options.

Tabone M, Pellicano R. Tabone M, et al. Minerva Gastroenterol Dietol. 2006 Mar;52(1):47-52. Minerva Gastroenterol Dietol. 2006. PMID: 16554706 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page